Giuseppe Migliorisi
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Clinical, genomic, and functional characterization of vancomycin-resistant Enterococci from immunocompromised patients: insights into epithelial dysfunction and bloodstream infections.
Journal: Frontiers in cellular and infection microbiology
Published: October 15, 2025
Integrating an LFA Carbapenemase Detection System into the Laboratory Diagnostic Routine: Preliminary Data and Effectiveness Against Enzyme Variants.
Journal: Diagnostics (Basel, Switzerland)
Published: May 02, 2025
Sequencing Analysis of Invasive Carbapenem-Resistant Klebsiella pneumoniae Isolates Secondary to Gastrointestinal Colonization.
Journal: Microorganisms
Published: December 12, 2024
The volatile organic compounds detection in MDR Gram-negatives antimicrobial susceptibility testing: Results from a four-month laboratory experience.
Journal: Diagnostic microbiology and infectious disease
Published: July 13, 2024
Molecular diversity in fusidic acid-resistant Methicillin Susceptible Staphylococcus aureus.
Journal: JAC-antimicrobial resistance
Published: June 03, 2024
The Impact of Enterococcus spp. in the Immunocompromised Host: A Comprehensive Review.
Journal: Pathogens (Basel, Switzerland)
Published: April 20, 2024
Bacterial Infections in Intensive Care Units: Epidemiological and Microbiological Aspects.
Journal: Antibiotics (Basel, Switzerland)
Published: February 16, 2024
The molecular detection of carbapenem markers with a two-levels amplification screening protocol: epidemiological and resistome insights.
Journal: Frontiers in microbiology
Published: November 29, 2023
The Rapid Phenotypic Susceptibility Testing in Real-Life Experience: How the MIC Values Impact on Sepsis Fast Diagnostic Workflow.
Journal: Diagnostics (Basel, Switzerland)
Published: November 18, 2023
Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion.
Journal: Antibiotics (Basel, Switzerland)
Published: September 14, 2023
Elexacaftor-Tezacaftor-Ivacaftor as a Final Frontier in the Treatment of Cystic Fibrosis: Definition of the Clinical and Microbiological Implications in a Case-Control Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 12, 2022
Resistance to Echinocandins Complicates a Case of Candida albicans Bloodstream Infection: A Case Report.
Journal: Journal of fungi (Basel, Switzerland)
Published: March 31, 2021
Last Updated: 09/26/2026